Boston Scientific schedules November 11 event while Boston Scientific stock costs EUR 40.98

Published on 10/27/2026 at 11:44 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Boston Scientific joins Stifel's November 11 conference. Boston Scientific stock costs EUR 40.98 on October 27, 2026. Revenue was USD 5.44 billion in the second quarter.

Dates frame the next catalyst

Boston Scientific will join Stifel's conference on November 11, 2026.
Second-quarter revenue reached USD 5.44 billion, up 7.50 percent year over year.
Boston Scientific stock traded at EUR 40.98 at 11:38 a.m. CEST at Lang & Schwarz on October 27, 2026.

Boston Scientific, US1011371077, Illustration mit AI erstellt.

Boston Scientific (ISIN US1011371077) stock was trading at EUR 40.98 at Lang & Schwarz on October 27, 2026 at 11:38 a.m. CEST. Boston Scientific said on October 26, 2026 that it will participate in Stifel's Healthcare Conference on November 11, 2026. The scheduled appearance comes one day before the company's next reported results date.

Revenue growth meets a tougher setup

Boston Scientific generated USD 5.44 billion in revenue in the second quarter of 2026, up 7.50 percent from USD 5.06 billion in the same quarter of 2025, while net income reached USD 907.0 million versus USD 793.0 million. MarketBeat reported those figures and the company's third-quarter guidance of USD 0.80 to USD 0.82 in adjusted earnings per share.

The analyst backdrop has become more cautious. Markets Insider reported on October 26, 2026 that Stifel lowered its target from USD 60.00 to USD 55.00 while keeping a Buy rating.

What does the November event mean?

The conference gives management a fresh venue to discuss demand, execution and the effect of the operating changes announced this fall. On October 7, 2026, Boston Scientific named Joseph M. Fitzgerald chief operating officer effective January 1, 2027, and said three reportable segments would begin at the same time. The structure will cover Interventional Therapies, Rhythm Solutions and MedSurg.

Three dates shape the timeline

On July 29, 2026, Boston Scientific reported USD 5.44 billion in second-quarter revenue. On October 7, 2026, the company announced Fitzgerald's appointment and the three-segment structure. On October 26, 2026, it scheduled the November 11 conference, with an approximately 8:00 a.m. ET question-and-answer session.

Results arrive before the conference

MarketBeat identified October 28, 2026 before the market open as the next reporting date. The next dated investor event is the November 11, 2026 Stifel conference.

Stock price and valuation context

Boston Scientific's primary listing is on the NYSE, where the stock was last quoted at USD 45.58 on October 26, 2026 at 4:00 p.m. ET. The market capitalization was USD 66.1 billion at that time, while the 52-week range was USD 41.39 to USD 105.65. The euro quotation was trading at EUR 40.98 at Lang & Schwarz on October 27, 2026 at 11:38 a.m. CEST. The further course of trading is shown by the continuously updated real-time quote of Boston Scientific stock.